# The Conundrum of Spinal Metastases—A Review of Current Management

**Authors:** Bogdan Florin Iliescu, Daniel Ilie Rotariu, Loredana Mariana Agavriloaei, Bogdan Costachescu

PMC · DOI: 10.3390/jcm14207279 · Journal of Clinical Medicine · 2025-10-15

## TL;DR

This review discusses modern approaches to managing spinal metastases, highlighting minimally invasive surgery and hybrid therapies as promising alternatives to traditional methods.

## Contribution

The paper introduces the potential of hybrid therapies and advanced prognostic tools for personalized treatment of spinal metastases.

## Key findings

- Minimally invasive spinal surgery reduces blood loss, hospitalization, and infection rates compared to open surgery.
- Hybrid approaches combining separation surgery and stereotactic radiosurgery improve local tumor control in certain cancers.
- Frameworks like NOMS, LMNOP, and NESMS guide clinical decisions in spinal metastasis management.

## Abstract

Spinal metastasis remains a significant clinical issue, frequently resulting in substantial pain and disability among cancer patients. Conventional management strategies have historically included chemotherapy, radiotherapy, and open surgical intervention. However, advancements in minimally invasive spinal surgery (MISS) have notably shifted the therapeutic landscape. This review examines recent evidence surrounding MISS, directly comparing it to traditional open procedures. Current literature demonstrates that MISS typically results in reduced intraoperative blood loss, shorter hospitalization durations, decreased infection rates, and functional outcomes that are at least equivalent—if not superior—to those of open surgery. Additionally, the emergence of hybrid therapeutic approaches—specifically, the utilization of separation surgery followed by stereotactic radiosurgery—has shown promise in achieving local tumor control, particularly in select malignancies. This narrative review also evaluates contemporary clinical decision-making frameworks such as NOMS, LMNOP, and NESMS. Further, it advocates for the integration of advanced prognostic tools and tumor genomics to enable more personalized treatment strategies for individuals with spinal metastasis.

## Full-text entities

- **Diseases:** cancer (MESH:D009369), Spinal Metastases (MESH:D009362), blood loss (MESH:D016063), disability (MESH:D009069), pain (MESH:D010146), infection (MESH:D007239)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12565418/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12565418/full.md

## References

58 references — full list in the complete paper: https://tomesphere.com/paper/PMC12565418/full.md

---
Source: https://tomesphere.com/paper/PMC12565418